`J3570` Laetrile amygdalin vit b17

Laetrile, amygdalin, vitamin b17

Medicare coverage: Non-covered by Medicare
Status: active (October 2026 file)

Medically Unlikely Edits (effective October 1, 2026)

Practitioner: max 0 units per day (clinical), rationale: CMS Policy
Outpatient hospital: max 0 units per day (clinical), rationale: CMS Policy
DME supplier: max 0 units per day (clinical), rationale: CMS Policy

Medicare pricing for J3570

Physician Fee Schedule (CY 2026, RVU26D)

Status N: non-covered service.

Payer policies and prior authorization for J3570

Payer coverage policies that name J3570

J3570 appears in 3 coverage policies from Aetna, Capital Blue Cross.

Payer	Policy	Role in policy	Reviewed	Document
Aetna	Complementary and Alternative Medicine (0388)	not covered	Jun 25, 2026	payer document
Aetna	Injectable Medications (0020)	listed, no stance (range J3570-J3590)	Mar 5, 2026	payer document
Capital Blue Cross	Experimental and Investigational Procedures (MP 4.002) Procedure codes: Injections	listed, no stance	Sep 1, 2026	payer document

Medicaid fee-for-service

Prior authorization required or conditional in IN.

VT: $0.00 (outpatient_hospital_opps), effective Feb 1, 2026
WY: $0.00 (outpatient_hospital_apc, Children's Hospitals), effective Apr 1, 2026

From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.

J3570 Laetrile amygdalin vit b17